These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36197228)

  • 1. Increased percentage of apoptotic and CTLA-4 (CD152) expressing cells in CD4+/CD8+ cells in COVID-19 patients.
    Zahran AM; Nafady-Hego H; Rashad A; El-Badawy O; Nasif KA; Mostafa AT; Osman HA; Dongol EM; Hashim AA; Abdelrazek GM; Abd Elrahman NH; Nafady A
    Medicine (Baltimore); 2022 Sep; 101(38):e30650. PubMed ID: 36197228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy with recombinant human erythropoietin decreases percentage of CD152(+) lymphocytes in primary glomerulonephritis haemodialysis patients.
    Trzonkowski P; Myśliwska J; Debska-Slizień A; Bryl E; Rachoń D; Myśliwski A; Rutkowski B
    Nephrol Dial Transplant; 2002 Jun; 17(6):1070-80. PubMed ID: 12032199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
    Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
    Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
    Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
    J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.
    Ayukawa H; Matsubara T; Kaneko M; Hasegawa M; Ichiyama T; Furukawa S
    Clin Exp Immunol; 2004 Jul; 137(1):151-5. PubMed ID: 15196256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations.
    Sweiss NJ; Salloum R; Gandhi S; Alegre ML; Sawaqed R; Badaracco M; Pursell K; Pitrak D; Baughman RP; Moller DR; Garcia JG; Niewold TB
    PLoS One; 2010 Feb; 5(2):e9088. PubMed ID: 20140091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.
    Wongjitrat C; Sukwit S; Chuenchitra T; Seangjaruk P; Rojanasang P; Romputtan P; Srisurapanon S
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S54-9. PubMed ID: 23724456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ and CD8+ cell counts are significantly correlated with absolute lymphocyte count in hospitalized COVID-19 patients: a retrospective study.
    Liana P; Samosir AP; Sari NP; Andriani RAL; Verdiansah V; Hidayatullah H; Ahmad Z; Umar TP
    PeerJ; 2023; 11():e15509. PubMed ID: 37377785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
    Bellesi S; Metafuni E; Hohaus S; Maiolo E; Marchionni F; D'Innocenzo S; La Sorda M; Ferraironi M; Ramundo F; Fantoni M; Murri R; Cingolani A; Sica S; Gasbarrini A; Sanguinetti M; Chiusolo P; De Stefano V
    Br J Haematol; 2020 Oct; 191(2):207-211. PubMed ID: 32679621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.
    Gutiérrez-Bautista JF; Rodriguez-Nicolas A; Rosales-Castillo A; Jiménez P; Garrido F; Anderson P; Ruiz-Cabello F; López-Ruz MÁ
    Front Immunol; 2020; 11():596553. PubMed ID: 33324414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells.
    Abbadessa G; Maida E; Miele G; Lavorgna L; Marfia GA; Valentino P; De Martino A; Cavalla P; Bonavita S
    Mult Scler Relat Disord; 2022 Apr; 60():103740. PubMed ID: 35305426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Coronavirus Disease 2019 (COVID-19) on Peripheral Blood Lymphocytes and Their Subsets in Children: Imbalanced CD4
    Mahmoudi S; Yaghmaei B; Sharifzadeh Ekbatani M; Pourakbari B; Navaeian A; Parvaneh N; Haghi Ashtiani MT; Mamishi S
    Front Pediatr; 2021; 9():643299. PubMed ID: 33937149
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphopenia with Altered T Cell Subsets in Hospitalized COVID-19 Patients in Pune, India.
    Suryawanshi P; Takbhate B; Athavale P; Jali P; Memane N; Mirza S; Karandikar M; Kakrani AL; Kanitkar S; Gandham N; Barthwal MS; Dole S; Chaturvedi S; Pawale S; Tripathy A; Bhawalkar JS; Tripathy S
    Viral Immunol; 2023 Apr; 36(3):163-175. PubMed ID: 36897333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent.
    Gattinoni L; Ranganathan A; Surman DR; Palmer DC; Antony PA; Theoret MR; Heimann DM; Rosenberg SA; Restifo NP
    Blood; 2006 Dec; 108(12):3818-23. PubMed ID: 16882704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].
    Li H; Liu Y; Liu Y; Liu J; Zhao D; Wang Y; Cheng Y
    Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):755-760. PubMed ID: 29167005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of CD8 marker on T-cells in COVID-19 patients.
    Ganji A; Farahani I; Khansarinejad B; Ghazavi A; Mosayebi G
    Blood Cells Mol Dis; 2020 Jul; 83():102437. PubMed ID: 32325421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte Phenotyping and HLA-DR Expression over the Course of COVID-19 Infection in Patients with Different Disease Severity.
    Asmaa-Nafady ; Alaa-Rashad ; Nafady-Hego H; Nasif KA; Ebtessam-Elgezawy ; Elrahman NA; Osman HA
    Clin Lab; 2022 May; 68(5):. PubMed ID: 35536080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.